Loading...
Market
What will be the outcome of UK regulators' investigation into Novo Nordisk's undisclosed payments by the end of 2024?
2
Resolution / Starting Odds
No further action • 25%
Additional fines • 25%
Settlement reached • 25%
Criminal charges • 25%
Official announcements from UK regulators
Story
Novo Nordisk Reprimanded by UK Regulators for £7.8 Million Undisclosed Payments
Jul 5, 2024, 02:16 PM
Danish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and expenses paid to individuals and organizations in the healthcare sector in Britain. The undisclosed payments amount to approximately £7.8 million.
View original story
Similar markets
No action taken • 25%
Recommendations for price reductions • 25%
Legislation introduced • 25%
Other • 25%
Approve without conditions • 25%
Approve with conditions • 25%
Block the acquisition • 25%
Extend review period • 25%
Fine imposed • 25%
Additional recalls • 25%
No further action • 25%
Other • 25%
FTC files lawsuit • 25%
FTC issues warning • 25%
FTC takes no action • 25%
FTC reaches settlement • 25%
Fines imposed • 25%
Regulations introduced • 25%
No action taken • 25%
Other • 25%
Acknowledge risk and issue warning • 25%
Deny risk and continue marketing • 25%
Initiate further studies • 25%
Discontinue affected products • 25%
Resolved as planned • 25%
Resolved for more than $70 million • 25%
Resolved for less than $70 million • 25%
Not resolved • 25%
FTC wins all lawsuits • 25%
FTC wins some lawsuits • 25%
FTC loses all lawsuits • 25%
Settlements reached • 25%
